SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antigen vaccination
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
procedure
Supplier: international · SCTID 840534001
Also known as (15)
- 2019 novel coronavirus antigen immunisation
- 2019 novel coronavirus antigen immunization
- 2019 novel coronavirus antigen vaccination
- 2019-nCoV (novel coronavirus) antigen vaccination
- 2019-nCoV antigen immunisation
- 2019-nCoV antigen immunization
- 2019-nCoV antigen vaccination
- Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen
- COVID-19 antigen immunisation
- COVID-19 antigen immunization
- COVID-19 antigen vaccination
- SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antigen vaccination
- SARS-CoV-2 antigen immunization
- SARS-CoV-2 antigen vaccination
- Severe acute respiratory syndrome coronavirus 2 antigen vaccination